ENVISIONING THE FUTURE
OF NON-INVASIVE MEDICAL DIAGNOSTICS
Redefining Non-Invasive, Real-Time Medical Diagnostics
Avalyra’s non-invasive biophotonic platform builds on 30+ years of
research and is designed with the goal of delivering near real-time
hemodynamic and blood analyte monitoring – first of its kind.
A Scalable Technology Platform with Multiple Potential Market Applications
Launching with four high-impact clinical use cases.
Maternal Health
Because postpartum hemorrhage remains a leading cause of maternal mortality.
Traumatic Hemorrhage
Because internal hemorrhage-related mortality remains a leading cause of death in the U.S.
Non-Invasive Glucose Monitoring
On path to deliver on the long-promised future: no pricks, at-home glucose monitoring.
Dialysis
Because patients are frequently over- or under-treated, with fluid imbalances contributing to hundreds of thousands of hospitalizations a year.
Avalyra Biophotonics is an IP-first MedTech entity with proprietary technology, working towards the promise of non-invasive diagnostics for remote, telehealth, at-home, and clinical care environments.
Avalyra Biophotonics is Focused on the Future of Non-Invasives.
Insight at the speed of light
Our Mission:
Give clinicians, care teams, and patients the clarity they need - when it matters most.
Multiple device form factors for various use-cases and applications in development. Concept visualization for illustration purposes. Device not yet FDA-approved.